UBS Group’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.93M | Buy |
422,048
+136,560
| +48% | +$1.23M | ﹤0.01% | 4314 |
|
|
2025
Q4 | $2.56M | Buy |
285,488
+67,392
| +31% | +$637K | ﹤0.01% | 4723 |
|
|
2025
Q3 | $2.07M | Buy |
218,096
+63,912
| +41% | +$641K | ﹤0.01% | 4916 |
|
|
2025
Q2 | $1.36M | Sell |
154,184
-8,880
| -5% | -$72.1K | ﹤0.01% | 5174 |
|
|
2025
Q1 | $1.22M | Sell |
163,064
-180,754
| -53% | -$1.44M | ﹤0.01% | 5115 |
|
|
2024
Q4 | $2.87M | Buy |
343,818
+323,884
| +1,625% | +$2.76M | ﹤0.01% | 4376 |
|
|
2024
Q3 | $138K | Buy |
19,934
+7,002
| +54% | +$47.5K | ﹤0.01% | 6125 |
|
|
2024
Q2 | $63.4K | Sell |
12,932
-30,016
| -70% | -$142K | ﹤0.01% | 6502 |
|
|
2024
Q1 | $249K | Buy |
42,948
+7,838
| +22% | +$48.2K | ﹤0.01% | 5699 |
|
|
2023
Q4 | $230K | Buy |
35,110
+16,368
| +87% | +$76.6K | ﹤0.01% | 5700 |
|
|
2023
Q3 | $90.3K | Sell |
18,742
-1,350
| -7% | -$6.74K | ﹤0.01% | 5893 |
|
|
2023
Q2 | $102K | Buy |
20,092
+15,953
| +385% | +$86K | ﹤0.01% | 5990 |
|
|
2023
Q1 | $22.8K | Sell |
4,139
-2,842
| -41% | -$15K | ﹤0.01% | 6983 |
|
|
2022
Q4 | $32K | Buy |
6,981
+6,004
| +615% | +$30.5K | ﹤0.01% | 7172 |
|
|
2022
Q3 | $6K | Sell |
977
-4,821
| -83% | -$27.3K | ﹤0.01% | 9081 |
|
|
2022
Q2 | $26K | Buy |
+5,798
| New | +$26.4K | ﹤0.01% | 6570 |
|
|
2022
Q1 | – | Sell |
-10,499
| Closed | -$92K | – | 11002 |
|
|
2021
Q4 | $92K | Buy |
+10,499
| New | +$93.7K | ﹤0.01% | 6389 |
|
|
2021
Q2 | – | Sell |
-13,283
| Closed | -$122K | – | 9897 |
|
|
2021
Q1 | $122K | Buy |
+13,283
| New | +$116K | ﹤0.01% | 5812 |
|
|
2020
Q2 | – | Sell |
-1,739
| Closed | -$6K | – | 8424 |
|
|
2020
Q1 | $6K | Buy |
+1,739
| New | +$9.62K | ﹤0.01% | 7242 |
|
|
2019
Q4 | – | Sell |
-1
| Closed | – | – | 8465 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 8306 |
|
|
2019
Q2 | $0 | Sell |
1
-46
| -98% | -$1.16K | ﹤0.01% | 8210 |
|
|
2019
Q1 | $1K | Sell |
47
-134
| -74% | -$4.93K | ﹤0.01% | 7570 |
|
|
2018
Q4 | $5K | Buy |
+181
| New | +$7.32K | ﹤0.01% | 7567 |
|
|
2018
Q3 | – | Sell |
-219
| Closed | -$23K | – | 8318 |
|
|
2018
Q2 | $23K | Buy |
219
+115
| +111% | +$11.2K | ﹤0.01% | 6611 |
|
|
2018
Q1 | $14K | Buy |
104
+56
| +117% | +$5.42K | ﹤0.01% | 6673 |
|
|
2017
Q4 | $3K | Sell |
48
-152
| -76% | -$9.17K | ﹤0.01% | 7550 |
|
|
2017
Q3 | $12K | Buy |
200
+148
| +285% | +$7.88K | ﹤0.01% | 6799 |
|
|
2017
Q2 | $3K | Sell |
52
-47
| -47% | -$3.1K | ﹤0.01% | 7308 |
|
|
2017
Q1 | $8K | Buy |
+99
| New | +$6.01K | ﹤0.01% | 6763 |
|
|
2016
Q2 | – | Sell |
-1,699
| Closed | -$394K | – | 8016 |
|
|
2016
Q1 | $394K | Buy |
1,699
+1,609
| +1,788% | +$390K | ﹤0.01% | 3952 |
|
|
2015
Q4 | $29K | Buy |
+90
| New | +$24.4K | ﹤0.01% | 6371 |
|
|
2015
Q3 | – | Sell |
-19
| Closed | -$6K | – | 8673 |
|
|
2015
Q2 | $6K | Buy |
+19
| New | +$4.14K | ﹤0.01% | 7803 |
|
Other funds holding ZVRA
WP
NCM
VCM
ACM
